AEPGX
Price
$57.59
Change
+$0.07 (+0.12%)
Updated
May 8 closing price
Net Assets
128.01B
FSOSX
Price
$15.24
Change
+$0.02 (+0.13%)
Updated
May 8 closing price
Net Assets
14.74B
Ad is loading...

AEPGX vs FSOSX

Header iconAEPGX vs FSOSX Comparison
Open Charts AEPGX vs FSOSXBanner chart's image
American Funds Europacific Growth A
Price$57.59
Change+$0.07 (+0.12%)
VolumeN/A
Net Assets128.01B
Fidelity Series Overseas
Price$15.24
Change+$0.02 (+0.13%)
VolumeN/A
Net Assets14.74B
AEPGX vs FSOSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEPGX vs. FSOSX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPGX is a Buy and FSOSX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
AEPGX has more cash in the bank: 128B vs. FSOSX (14.7B). FSOSX pays higher dividends than AEPGX: FSOSX (2.02) vs AEPGX (1.08). AEPGX was incepted earlier than FSOSX: AEPGX (41 years) vs FSOSX (6 years). AEPGX (0.85) is less costly to investors than FSOSX (0.01). FSOSX is a more actively managed with annual turnover of: 36.00 vs. AEPGX (30.00). FSOSX has a lower initial minimum investment than AEPGX: FSOSX (0) vs AEPGX (250). FSOSX annual gain was more profitable for investors over the last year : 12.27 vs. AEPGX (-0.70). FSOSX return over 5 years is better than : 74.01 vs. AEPGX (26.05).
AEPGXFSOSXAEPGX / FSOSX
Total Expense Ratio0.850.018,500%
Annual Report Gross Expense Ratio0.850.018,500%
Fund Existence41 years6 years-
Gain YTD7.20413.24454%
Front Load6%N/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets128B14.7B871%
Annual Yield % from dividends1.082.0254%
Returns for 1 year-0.7012.27-6%
Returns for 3 years20.7349.3242%
Returns for 5 years26.0574.0135%
Returns for 10 years17.06N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRVA25.071.75
+7.50%
Privia Health Group
REVB3.100.20
+6.92%
Revelation Biosciences Inc
TXO17.00N/A
N/A
TXO Partners LP
RAPT0.80N/A
-0.05%
RAPT Therapeutics
THC149.06-3.26
-2.14%
Tenet Healthcare Corp